FDA.reportPublic FDA data

HLA class II antibody identification panel IVD, kit, complement-dependent cytotoxicity (CDC)

Definition
A collection of reagents and other associated materials intended to be used for the identification of one or multiple antibodies to HLA class II antigens in a clinical specimen, using lymphocyte antigens together with a complement-dependent cytotoxicity (CDC) method.
GUDID devices
2
Last updated
2019-04-02 21:21:59

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
07611969952946Lymphoscreen DR 30 x 2Bio-Rad Medical Diagnostics GmbH8233502015-07-01
07611969965717Lymphoscreen DR 30x2Bio-Rad Medical Diagnostics GmbH8233502018-03-08